Kumar  Budur net worth and biography

Kumar Budur Biography and Net Worth

Chief Medical and Scientific Officer of Harmony Biosciences

Kumar Budur, MD, MS, is the Chief Medical and Scientific Officer at Harmony Biosciences. He leads R&D strategy and Medical Affairs for Harmony Biosciences, and oversees the functional areas of Clinical strategy, Clinical Operations, Regulatory Affairs, Pharmacovigilance, Biostatistics, Portfolio Management and Medical Affairs.

Prior to Harmony Biosciences, Dr. Budur spent approximately 6 years each at AbbVie and Takeda, where he held positions of increasing responsibilities. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of Development. Dr. Budur was involved with four New Drug Applications (NDAs) and was the lead for the registration clinical trials, submission, and approval process of two NDAs.

Dr. Budur was trained at Cambridge University in the UK, and Cleveland Clinic and completed his Residency in Psychiatry and Fellowships in Neurophysiology and Sleep Medicine. He is Board Certified in Psychiatry and Sleep Medicine and holds a master’s degree in clinical research from Case Western Reserve University. Dr. Budur has published over 45 original research papers in peer reviewed journals, edited four books, and chaired National and International seminars and symposiums.

What is Kumar Budur's net worth?

The estimated net worth of Kumar Budur is at least $765.08 thousand as of September 4th, 2026. Dr. Budur owns 18,615 shares of Harmony Biosciences stock worth more than $765,077 as of September 11th. This net worth approximation does not reflect any other assets that Dr. Budur may own. Learn More about Kumar Budur's net worth.

How do I contact Kumar Budur?

The corporate mailing address for Dr. Budur and other Harmony Biosciences executives is 630 W GERMANTOWN PIKE SUITE 215, PLYMOUTH MEETING PA, 19462. Harmony Biosciences can also be reached via phone at 484-539-9800 and via email at [email protected]. Learn More on Kumar Budur's contact information.

Has Kumar Budur been buying or selling shares of Harmony Biosciences?

In the last ninety days, Kumar Budur has sold $1,453,273.84 in Harmony Biosciences stock. Most recently, Kumar Budur sold 28,454 shares of the business's stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $42.96, for a transaction totalling $1,222,383.84. Following the completion of the sale, the insider now directly owns 13,115 shares of the company's stock, valued at $563,420.40. Learn More on Kumar Budur's trading history.

Who are Harmony Biosciences' active insiders?

Harmony Biosciences' insider roster includes Kumar Budur (Chief Medical and Scientific Officer), Jeffrey Dayno (Insider), Jeffrey Dierks (Insider), John Jacobs (CEO), Sandip Kapadia (Chief Financial Officer and Chief Administrative Officer), and Andreas Wicki (Director). Learn More on Harmony Biosciences' active insiders.

Are insiders buying or selling shares of Harmony Biosciences?

In the last year, insiders at the sold shares 5 times. They sold a total of 84,594 shares worth more than $3,385,529.49. The most recent insider tranaction occured on September, 8th when insider Kumar Budur sold 28,454 shares worth more than $1,222,383.84. Insiders at Harmony Biosciences own 11.0% of the company. Learn More about insider trades at Harmony Biosciences.

Information on this page was last updated on 9/8/2026.

Kumar Budur Insider Trading History at Harmony Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2026Sell28,454$42.96$1,222,383.8413,115View SEC Filing Icon  
9/4/2026Sell5,500$41.98$230,890.0018,615View SEC Filing Icon  
See Full Table

Kumar Budur Buying and Selling Activity at Harmony Biosciences

This chart shows Kumar Budur's buying and selling at Harmony Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Harmony Biosciences Company Overview

Harmony Biosciences logo
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More

Today's Range

Now: $41.10
Low: $40.93
High: $41.72

50 Day Range

MA: $38.04
Low: $33.50
High: $42.86

2 Week Range

Now: $41.10
Low: $25.52
High: $43.49

Volume

736,799 shs

Average Volume

700,193 shs

Market Capitalization

$2.39 billion

P/E Ratio

13.34

Dividend Yield

N/A

Beta

0.93